Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Factors accounting for asthma variability: achieving optimal symptom control for individual patients


Asthma is a variable disease, and various factors can lead to an increase (or decrease) in asthma symptoms and the level of asthma control. Pub Med was searched for recent articles dealing with asthma variability, environmental factors and co-morbid conditions that affect asthma control, and for publications which identified tools to facilitate patients' response to asthma variability. Variability in asthma symptoms may be a response to the individual's environment (e.g. seasonal variation, cigarette smoke, and air pollutants) or personal factors (e.g. inhaler technique, pregnancy, exercise). Co-morbid diseases such as allergic rhinitis may also impact significantly on asthma variability and control. Documenting asthma variability and assessing both adherence and possible triggers over time may allow patients and physicians to develop treatment programmes that anticipate, rather than follow, changes in the level of asthma symptoms. Personalised asthma control plans which take into account factors affecting symptom variability may enable patients to modify medication and their environment prophylactically in anticipation of a known trigger or at the first sign of an asthma exacerbation.

Author information



Corresponding author

Correspondence to Barbara P Yawn.

Ethics declarations

Competing interests

The author is a member of the National Institutes of Health's National Asthma Education and Prevention Program and the National Heart, Lung, and Blood Institute's Expert Review Panel 3 for updating asthma guidelines. She serves on the National Patient and Professional Asthma Advisory Committee for AstraZeneca and the Schering-Plough National Respiratory Disease Leadership Council, and has served as a consultant to Altana Pharma for asthma-related topics. She also has research grants in asthma-related topics from the National Heart, Lung, and Blood Institute, and the Agency for HealthCare Research and Quality and Schering-Plough Integrated Therapeutics.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yawn, B. Factors accounting for asthma variability: achieving optimal symptom control for individual patients. Prim Care Respir J 17, 138–147 (2008).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing